NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Thursday:
Cooper Companies Inc., up $31.92 to $440.12.
Chinese regulators approved the use of the medical device maker's CooperVision MiSight one-day contact lenses.
Hims & Hers Health Inc., up 82 cents to $8.39.
The teleheath consultation company gave investors an encouraging sales forecast after reporting solid second-quarter financial results.
Sonos Inc., up $2.58 to $37.38.
The maker of wireless speakers and home sound systems reported a surprise fiscal third-quarter profit.
Jacobs Engineering Group Inc., up $3.41 to $139.56.
The engineering company was selected to carry out modifications to extend the life of South Africa's sole nuclear power plant.
UTZ Brands Inc., down $1.56 to $19.27.
The maker of potato chips and other snacks reported disappointing second-quarter earnings and warned of higher costs.
Lordstown Motors Corp., up 16 cents to $5.74.
The electric truck maker said it will begin limited production of its Endurance vehicle in September and expects regulatory approval in December or January.
Aspen Technology Inc., down $16.83 to $125.87.
The software maker's fiscal fourth-quarter revenue fell short of analysts' forecasts.
Carnival Corp., down 63 cents to $23.36.
Cruise lines and other travel-related companies fell as a COVID-19 resurgence threatens the industry's recovery.
Before you consider Sonos, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sonos wasn't on the list.
While Sonos currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
